[topsearch__bar__shortcode]

December 20, 2024

Humacyte (HUMA) Stock Gains Pre-Market Momentum Following FDA Nod

Leave a Comment / Morning News, US Stocks /

Following a major regulatory approval, Humacyte, Inc.’s (NASDAQ: HUMA) shares surged 68.50% to $5.83 as of the last check during the pre-market trading session. The acellular, tissue-engineered vessel SYMVESS has received complete approval from the U.S. Food and Drug Administration (FDA) to treat people with arterial injuries in their extremities that need immediate revascularization, especially […]

Humacyte (HUMA) Stock Gains Pre-Market Momentum Following FDA Nod Read More »

Mainz Biomed (MYNZ) Stock Soars In Pre-Hour Session On A New Partnership

Leave a Comment / Morning News, US Stocks /

After the announcement of a high-profile partnership, Mainz Biomed N.V. (NASDAQ: MYNZ) stock saw a sharp increase on Thursday. During the regular trading session, MYNZ shares increased 26.19%, finishing at $4.77. Still in the pre-market session today, the stock is on the rise of 14.05% to $5.44, reflecting investor confidence in the company’s new deal.

Mainz Biomed (MYNZ) Stock Soars In Pre-Hour Session On A New Partnership Read More »

BioAge (BIOA) Shares Climb On The Back Of Promising New Collaboration

Leave a Comment / Market News /

BioAge Labs, Inc.’s (NASDAQ: BIOA) stock witnessed a significant uptick on Thursday, closing at $5.17 after increasing 20.23%. The announcement of a strategic, multi-year research partnership with Novartis to further its understanding of exercise biology and aging was the catalyst for this notable increase in stock value. Strategic Alliance with Novartis BioAge Labs unveiled a

BioAge (BIOA) Shares Climb On The Back Of Promising New Collaboration Read More »

Personalis (PSNL) Stock Jumps After-Market Following Major Business Moves

Leave a Comment / Business, US Stocks /

The recent updates in its business plan caused a notable spike in Personalis, Inc. (NASDAQ: PSNL) shares. During Thursday’s regular trading session, PSNL’s shares increased 47.75%, finishing at $5.26. After hours, the stock maintained its upward trajectory, climbing an additional 12.93% to $5.94. Strategic Partnerships with Merck and Moderna Personalis revealed it had secured significant

Personalis (PSNL) Stock Jumps After-Market Following Major Business Moves Read More »

Patent Acquisition Fuels Mangoceuticals (MGRX) Stock Surge During Extended Trading

Leave a Comment / Business /

On Thursday, the shares of Mangoceuticals, Inc. (NASDAQ: MGRX) surged on the announcement of a strategic patent purchase. The revelation caused MGRX stock to rise 14.76% on the US stock charts to $2.80 in after-market trade, demonstrating that investors had high confidence in the company’s innovative direction. A Revolution in Solutions Based on Functional Mushrooms

Patent Acquisition Fuels Mangoceuticals (MGRX) Stock Surge During Extended Trading Read More »

Alpha Modus (AMOD) Stock Gains Momentum In Extended Session

Leave a Comment / Market News /

Following reports of legal action initiation, Alpha Modus Holdings, Inc. (NASDAQ: AMOD) saw a sharp increase in share price. After a notable 34.75% increase during regular trading hours, when it closed at $3.49, AMOD stock increased 18.91% to $4.15 during Thursday’s extended trading session. The increased trend comes after Alpha Modus, Corp., a subsidiary of

Alpha Modus (AMOD) Stock Gains Momentum In Extended Session Read More »

KULR Sees After-Market Stock Boost Amid Listing Compliance News

Leave a Comment / Market News /

Following its announcement of compliance with the NYSE American LLC listing standards, KULR Technology Group, Inc. (NYSE: KULR) saw a significant increase in the value of its shares on Thursday. The stock increased 6.71% in after-hours trading to reach $2.39 after rising 7.69% during the regular session to close at $2.24. The notification confirmed that

KULR Sees After-Market Stock Boost Amid Listing Compliance News Read More »

Stocks
Telegraph

At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.

About

Categories

Social Links

Facebook Twitter Youtube Instagram Linkedin